BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23633265)

  • 1. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.
    Geybels MS; Wright JL; Holt SK; Kolb S; Feng Z; Stanford JL
    Prostate; 2013 Aug; 73(11):1214-22. PubMed ID: 23633265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
    Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
    Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
    Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
    Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
    Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
    Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations among statins, preventive care, and prostate cancer mortality.
    Kumar A; Riviere P; Luterstein E; Nalawade V; Vitzthum L; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):475-485. PubMed ID: 32029930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
    Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
    BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.
    Wu SY; Fang SC; Shih HJ; Wen YC; Shao YJ
    Eur J Cancer; 2019 May; 112():109-117. PubMed ID: 30827745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
    Anderson-Carter I; Posielski N; Liou JI; Khemees TA; Downs TM; Abel EJ; Jarrard DF; Richards KA
    Urol Oncol; 2019 Feb; 37(2):130-137. PubMed ID: 30528885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP17 polymorphisms and prostate cancer outcomes.
    Wright JL; Kwon EM; Lin DW; Kolb S; Koopmeiners JS; Feng Z; Ostrander EA; Stanford JL
    Prostate; 2010 Jul; 70(10):1094-101. PubMed ID: 20503394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
    Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.
    Lehman DM; Lorenzo C; Hernandez J; Wang CP
    Diabetes Care; 2012 May; 35(5):1002-7. PubMed ID: 22456867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study.
    Matthes KL; Pestoni G; Korol D; Van Hemelrijck M; Rohrmann S
    Urol Oncol; 2018 Jun; 36(6):309.e15-309.e23. PubMed ID: 29576269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and prostate cancer risk in a large population-based setting.
    Boudreau DM; Yu O; Buist DS; Miglioretti DL
    Cancer Causes Control; 2008 Sep; 19(7):767-74. PubMed ID: 18322813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
    Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
    Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
    Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
    Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
    Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer.
    Khan S; Chang SH; Hicks V; Wang M; Grubb RL; Drake BF
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):707-712. PubMed ID: 34811499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.